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Achroma Virus: A 




The Achroma virus is a virtual virus invented as a 
part of the virtual virus project in BIOL 450/Virology 
during the Fall of 2018. Viruses are tiny, abundant, 
and diverse packets of genetic material enclosed in a 
protein capsid. Viruses can infect many different types 
of life, from plants and animals to bacteria. In order to 
propagate, viruses need to infect a host cell, and hijack 
a living cell’s machinery to build more of themselves. 
Some viruses destroy the host cell in order to release 
the newly synthesized viruses, a process known as 
lysis. Lysis is particularly damaging when the target 
cell of a virus is a cell type that cannot be regenerated 
after being lysed. A newly described virus, the 
Achroma virus, targets the photoreceptor cells specific 
to color vision, also known as the cones, of the human 
retina. Photoreceptor cells do not divide, which means 
that any colorblindness caused by viral damage to 
these cells is permanent (2,4). 
The first notable appearance of the Achroma 
virus was at an elementary school in the United States. 
The school nurse noticed an unusually high number 
of children showing signs of colorblindness during 
standard annual vision testing. The nurse decided 
to re-test some of the children three weeks later and 
noticed that some of the children who hadn’t appeared 
colorblind initially were beginning to show symptoms 
with time. She was concerned because colorblindness 
is normally a genetically linked trait and not 
something that develops over a period of a few weeks 
and spreads among a population. Upon investigation 
by additional medical professionals and specialists, it 
appeared that these students were losing color vision 
due to the destruction of the cone cells of their retinas. 
Intraocular fluid was taken from the eyes of several 
of the patients. DNA was isolated from this fluid and 
sequenced, which led to the discovery of the 
Achroma virus. 
The goal of this report is to compile all the 
current information pertaining to Achroma virus, 
including the structure of the virus, its life cycle, its 




The Achroma virus is a naked, icosahedral virus. 
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It is on average 90 nm in diameter. It has twelve viral 
ligands: one on each vertex. These viral ligands are 
known as ROY ligands and they interact with the 
GBIV receptors on the surface of photoreceptor cells. 
These names were taken from ROY G. BIV, which is 
an acronym for the colors of the rainbow (red, orange, 
yellow, green, blue, indigo, violet). The viral capsid is 
composed of a repeating pattern of two distinct units. It 
houses linear, non-segmented, double-stranded DNA. 
2. Life cycle
The entire virus enters the cell via receptor-mediated 
endocytosis (Fig. 2A). The virus attaches to the host 
photoreceptor cell when the viral ROY ligand binds 
to the GBIV receptor on the host cell surface. It is 
then endocytosed into the cell. Uncoating, or the 
degradation of the viral capsid, takes place in the 
endosome and the cytoplasm. Once the dsDNA is 
free of the capsid, it enters the nucleus via a nuclear 
pore (Fig. 2B).      
   Viral genome replication takes 
place in the nucleus. The viral genome 
encodes its own DNA polymerase, 
which is the enzyme that replicates 
the DNA. Photoreceptor cells are 
not actively dividing, so they are not 
duplicating their genome and using their 
own DNA polymerase. Therefore, it is 
more efficient for the virus to encode 
its own DNA polymerase and use the cellular protein 
manufacturing machinery to produce DNA. Also, 
the viral DNA polymerase includes a proofreading 
function, which helps to prevent mutations.
The virus relies on the photoreceptor cells’ RNA 
polymerase for transcription of its mRNAs. RNA 
polymerase is the enzyme that “reads” the genes on 
Figure 1. The structure of the Achroma virus. A – 
Outside view showing the icosahedral shape of the 
capsid as well as the repeating pattern. B – Inside 
view showing the viral genome inside the capsid. 
The ROY ligands can be seen in both images. The 
capsid of this model was made using plastic, fusible 
beads. The viral genome was made of plastic cord.
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DNA and transcribes them into a form (mRNA) that 
the cell can ultimately use to make protein. In order to 
attract the cellular transcription machinery, the virus 
has evolved sequences on its genome that mimic the 
cellular promoters that normally attract the machinery 
to the cellular DNA. The viral genome also codes for 
a CAP-snatching enzyme that 
steals 5’ CAPs from cellular 
mRNA and transfers them to 
viral mRNA. Because a 5’ CAP 
is a necessary starting place 
for the cellular translation 
machinery when translating 
mRNA into proteins, the action 
of this CAP-snatching enzyme 
simultaneously makes the viral 
mRNA more competitive and 
puts the cellular mRNA at a disadvantage. The virus 
also relies on cellular poly-A polymerase to synthesize 
the mRNA’s poly-A tails, which are another necessary 
component of mRNA for protein synthesis to occur. 
Any proteins synthesized by the cell’s ribosomes that 
will be part of the viral capsid or viral ligands will 
move back into the nucleus for assembly. Once the 
capsids are assembled, the viral genomes enter the 
capsids thus completing the assembly of the viral 
particle (Fig. 2C).
When enough of the newly synthesized viruses 
accumulate in the cell, the pressure builds up and 
the new viruses break the cell membrane. The cell 
is lysed, and the new viruses are released to infect 
another cell (Fig. 2D).
Figure 2. The life cycle of the Achroma virus. A - The virus 
enters the cell via receptor-mediated endocytosis. B - The 
viral capsid degrades in the endosome and cytoplasm. 
The dsDNA moves into the nucleus. DNA replication and 
transcription take place in the nucleus. Translation occurs 
in the cytoplasm when viral mRNA leaves the nucleus and 
is translated by a ribosome. C - Viral structural proteins 
move back into the nucleus and are assembled there. The 
viral genome is packaged in the empty capsids. D - The 
new viruses cause lysis of the cell.
This figure was prepared using Microsoft Powerpoint.
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3.     Immune system tricks
The immune system and viruses are in a continual 
evolutionary tug of war; viruses are constantly 
evolving ways to thwart the immune system and 
vice versa. The Achroma virus infects and lyses 
photoreceptor cells, which are located on the retina 
in the eye. The eye is one of the parts of the body 
that has immune privileged status. This means that 
the body has a limited immune response in this 
region. For example, a nonspecific immune response 
like inflammation is limited in the eye because 
inflammation would damage the delicate tissues there. 
The Achroma virus is able to establish itself in the eye 
without having to overcome some of the body’s usual 
immune responses (1). 
The Achroma virus also comes packaged with 
a specific protease, which is an enzyme that is 
responsible for cleaving or cutting a protein. This 
protease targets both MHC I and MHC II (Major 
Histocompatibility Complex I and II), which are key 
molecules on the surface of cells that help trigger an 
immune response. By damaging these proteins, the 
virus not only impedes the photoreceptor cells’ ability 
to signal an immune response, but it also impedes the 
microglial cells’ ability to signal one too. Microglial 
cells are immune macrophages found in the eye, 
and they cannot do their job and trigger an immune 
response without MHC II.
4.      Pathology
The virus enters the patient through the eye. Because 
it does not have an envelope, it can live on surfaces 
for up to a day. It can be easily transmitted by 
touching a contaminated surface and then rubbing 
the eyes. Symptoms of Achroma virus infection can 
mimic those of conjunctivitis or other eye infections, 
including watery eyes, discharge from eyes, and 
redness. The virus can be present in these fluids, and 
if they get on the patient’s hands the patient can then 
contaminate surfaces, thus facilitating the transfer of 
the virus to other individuals.
The Achroma virus targets the photoreceptor cells 
of the retina, which means that eventually it degrades 
the patient’s vision. Usually, the patient notices color 
vision declining first, because there are fewer cones 
than rods in the retina. Also, cones and rods are 
spatially separated, so the new virus can easily access 
many cones in one area. The patient also may notice 
eye “floaters” or other disturbances in vision. Rarely 
the Achroma infection has been observed to progress 
to complete blindness if the virus was left untreated. 
It is suspected that persistent inflammation triggered 
by large amounts of Achroma virus might be inflicting 
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extensive damage to rod cells and thus loss of vision 
(3). It is not known if other factors, for example, 
genetic variation or environmental exposures, 
contribute to this unfortunate outcome.
5.     Treatment and Therapeutic Use
Antiviral drugs are currently being developed to treat 
Achroma virus infections. The tests involve a drug that 
targets the viral MHC protease. The drug is injected 
directly into the posterior chamber of the affected eye 
to try and achieve the fastest effect. The best methods 
to prevent an Achroma virus infection are frequent 
hand washing and making sure contact lenses are kept 
in a clean and sanitary environment.
Since the Achroma virus can readily enter 
photoreceptor cells, there is research being done on 
using empty Achroma virus capsids to offer gene 
therapy to colorblind patients. Functional copies of 
genes for photopigments may be able to be packaged 
in the capsids and sent into photoreceptor cells. This 
research is still very new and further studies will need 
to be done to confirm the efficacy and safety of 
such techniques.
6. Impact on the Author
The creation of the Achroma virus through the virtual 
virus project has influenced how I will think about 
teaching science in my classroom in the future. Even 
though the material in this course was well above 
elementary level, I believe I can apply the principles 
of this project to my own elementary school classroom 
someday. This project was an engaging means of 
modelling the scientific process in a condensed but 
realistic way. It also required us to integrate both 
newly acquired knowledge and existing knowledge 
over the course of the semester. Applying the material 
in a meaningful way is more effective than just 
memorization. I think the creative aspect of this 
project enhances learning, because students are more 
excited and motivated to make the subject matter
their own. 
Acknowledgements
The author would like to express her gratitude to the 
Office of Undergraduate Research for sponsoring this 
project via the ATP Course-Embedded Grant. Also, 
she would like to thank Dr. Boriana Marintcheva for 
her guidance and support.
References
Forrester JV, Heping X. Good news-bad news: 
the Yin and Yang of immune privilege in the eye. 
Frontiers in Immunology. 3: 338.
Herrero Uribe L. Viruses, definitions and reality. 
Revista de Biología Tropical. 59 (3): 993-998.
292 BRIDGEWATER STATE UNIVERSITY |  THE UNDERGRADUATE REVIEW 2020
Purves D, Augustine GJ, Fitzpatrick D, et al. 
Anatomical Distribution of Rods and Cones. 
Neuroscience. 2nd edition. Sinaeur Associates; 
2001. 
Shors T. Understanding Viruses. 3rd edition. Jones 
and Bartlett Learning. 2017.
About the Author
Allyssa Richardson is graduating in Spring 2020 as an 
Elementary Education and Biology double major. Her 
project was completed for BIOL450/Virology under 
the mentorship of Dr. Boriana Marintcheva (Biological 
Sciences). In the future, Alyssa plans to pursue 
graduate studies at Bridgewater State University and 
eventually become a teacher at an elementary school.
